EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Peripheral Blood Leukocyte Ratios as Novel Biomarkers in Brain Glioma: A Comprehensive Systematic Review and Meta‐Analysis

Fatemeh Hasani iD, Kimia Jazi, Kimia Vakili, Armin Tafazolimoghadam, Mehrad Namazee, Mahdi Masrour, Mohammadreza Ghanbari Boroujeni, Hossein Gandomkar, Antonio L Teixeira, Erfan Ghoodjani, Mohammad Samadian, Fatemeh Sayehmiri und 1 weitere

Journal of Cellular and Molecular Medicine · 2026-01 · 30 (1)

DOI: 10.1111/jcmm.70974 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 08.01.2026. Verfasst von Fatemeh Hasani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Biomarkers, Tumor, Leukocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory biomarkers, such as leukocyte ratios, have emerged as promising tools for diagnosing and prognosticating brain gliomas. This study systematically reviewed and analysed the diagnostic and prognostic relevance of peripheral blood leukocyte ratios in glioma. Following the PRISMA guidelines, we conducted a systematic review and meta‐analysis by searching PubMed, Web of Science, and Scopus for studies published in English. Eligible studies evaluated the sensitivity, specificity, and area under the curve (AUC) of inflammatory ratios, as well as their associations with survival outcomes. Quality was assessed using the Newcastle‐Ottawa Scale. A total of 29 assessments with 13,189 observations compared the neutrophil‐to‐lymphocyte ratio (NLR) between glioma patients and non‐glioma groups, yielding a pooled standardised mean difference (SMD) of 0.445 (95% CI: 0.280–0.609, p < 0.0001; I 2 = 85.1%). When compared to healthy individuals (10 assessments, 4444 observations), glioma patients exhibited a significantly elevated NLR (SMD: 0.797, 95% CI: 0.576–1.019, p < 0.0001; I 2 = 87.5%). Compared to meningioma (5 assessments, 3227 observations), glioma patients had a significantly higher NLR (SMD: 0.352, 95% CI: 0.280–0.424, p < 0.0001; I 2 = 24.7%). In comparisons with brain metastasis (4 assessments, 428 observations), the difference was not significant (SMD: −0.112, p = 0.3315; I 2 = 44.6%). The platelet‐to‐lymphocyte ratio (PLR) (25 assessments, 12,085 observations) showed no significant difference between glioma and non‐glioma groups (SMD: 0.1291, p = 0.0836; I 2 = 81.4%). Similarly, the derived NLR (dNLR) was significantly higher in glioma patients than in non‐glioma groups (SMD: 0.2421, p < 0.0001; I 2 = 49.9%). The lymphocyte‐to‐monocyte ratio (LMR) was significantly lower in glioma compared to meningioma (SMD: −0.2989, p < 0.0001; I 2 = 0.0%). MLR analysis showed high heterogeneity ( I 2 = 99.5%) with non‐significant findings ( p = 0.4476). These findings suggest NLR and dNLR as potential biomarkers for glioma diagnosis. Peripheral blood leukocyte ratios, particularly NLR, represent valuable biomarkers for glioma diagnosis and prognosis. Further research is warranted to enhance their precision and clinical utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsBiomarkers, TumorLeukocytesHumansPrognosisLeukocyte CountLymphocytesNeutrophils

Stichwörter der Autor:innen

biomarkersgliomaleukocyte countneutrophil‐to‐lymphocyte ratiotumour

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Gastroenterology and Hepatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • Neuroscience Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Students Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran.

ORCID-Profile: Fatemeh Hasani

Zitieren

APA

Hasani, F., Jazi, K., Vakili, K., Tafazolimoghadam, A., Namazee, M., Masrour, M., Boroujeni, M. G., Gandomkar, H., Teixeira, A. L., Ghoodjani, E., Samadian, M., Sayehmiri, F., & Mousavinejad, S. A. (2026). Peripheral Blood Leukocyte Ratios as Novel Biomarkers in Brain Glioma: A Comprehensive Systematic Review and Meta‐Analysis. Journal of Cellular and Molecular Medicine, 30(1). https://doi.org/10.1111/jcmm.70974

Vancouver

Hasani F, Jazi K, Vakili K, Tafazolimoghadam A, Namazee M, Masrour M, et al. Peripheral Blood Leukocyte Ratios as Novel Biomarkers in Brain Glioma: A Comprehensive Systematic Review and Meta‐Analysis. Journal of Cellular and Molecular Medicine. 2026;30(1). doi:10.1111/jcmm.70974

BibTeX
@article{Hasani2026,
  author = {Hasani, Fatemeh and Jazi, Kimia and Vakili, Kimia and Tafazolimoghadam, Armin and Namazee, Mehrad and Masrour, Mahdi and Boroujeni, Mohammadreza Ghanbari and Gandomkar, Hossein and Teixeira, Antonio L and Ghoodjani, Erfan and Samadian, Mohammad and Sayehmiri, Fatemeh and Mousavinejad, Seyed Ali},
  title = {Peripheral Blood Leukocyte Ratios as Novel Biomarkers in Brain Glioma: A Comprehensive Systematic Review and Meta‐Analysis},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {1},
  doi = {10.1111/jcmm.70974}
}
Kostenlos starten →